What is Zymeworks's EPS (basic)?

Zymeworks (ZYME) reported EPS (basic) of -$0.59 in Q1 2026.

How has Zymeworks's EPS (basic) changed year-over-year?

Zymeworks's EPS (basic) decreased by 96.7% year-over-year, from -$0.30 to -$0.59.

What is the long-term trend for Zymeworks's EPS (basic)?

Over 3 years (2022 to 2025), Zymeworks's EPS (basic) has grown at a -17.2% compound annual growth rate (CAGR), from $1.90 to -$1.08.

What does EPS (basic) mean?

Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

Zymeworks ZYME EPS (Basic)

EPS (Basic) at other companies

PfizerPFE

$0.47-9.6%

AmgenAMGN

$3.37+4.7%

AnaptysBio, Inc.ANAB

-$1.84-43.8%

Viridian Therapeutics, Inc.VRDN

-$1.15-5.5%

AbCellera Biologics Inc.ABCL

-$0.14+6.7%

Stoke Therapeutics, Inc.STOK

-$0.79-141%

Other financials

Income statement

See full

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

See full

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

See full

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

See full

Market cap$1.79B+125%

Profitability

See full

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

See full

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zymeworks's EPS (basic)?: Zymeworks (ZYME) reported EPS (basic) of -$0.59 in Q1 2026.
How has Zymeworks's EPS (basic) changed year-over-year?: Zymeworks's EPS (basic) decreased by 96.7% year-over-year, from -$0.30 to -$0.59.
What is the long-term trend for Zymeworks's EPS (basic)?: Over 3 years (2022 to 2025), Zymeworks's EPS (basic) has grown at a -17.2% compound annual growth rate (CAGR), from $1.90 to -$1.08.
What does EPS (basic) mean?: Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.